GeneGlobe ID: DHS-005Z | Cat. No.: | QIAseq Targeted DNA Panels

QIAseq Targeted DNA Human Lung Cancer Panel

Kit containing ALL reagents (except indexes) for targeted DNA sequencing

Select a variant to see the price

Product Specification

Target List

Carcinoid-Endocrine Tumor
Atypical​
KRAS, PIK3CA (p110-alpha), TP53 (p53)
Typical​
PIK3CA (p110-alpha)
Carcinoma
Non-Small Cell Lung Cancer​
ALK, AMER1, APC, ATM, ADGRB3, BRAF, CDKN2A (P16INK4A), CTNNB1, EGFR (ERBB1), ERBB2 (HER-2, NEU), FGFR3, GRM8, HRAS, JAK2, KRAS, MET, MUC16, NF1, NFE2L2, NRAS, NTRK2, NTRK3, PDGFRA, PIK3CA (p110-alpha), PIK3CG, PKHD1, PTEN, RB1, RET, SMARCA4, STK11 (LKB1), TNFAIP3, TP53 (p53)
Small Cell Lung Cancer​
ALK, AMER1, ARID1A, ATM, ADGRB3, CDKN2A (P16INK4A), CREBBP (CBP), CTNNB1, DDR2, EGFR (ERBB1), EPHA5, ERBB4, FBXO7, FBXW7, FGFR1, FHIT, GRM8, HRAS, KDR (VEGFR3), KIT (CD117), KRAS, LRP1B, MET, KMT2D, MUC16, MYC, NF1, NOTCH1, NTRK1, NTRK2, NTRK3, PIK3CA (p110-alpha), PIK3CG, PIK3R1 (p85-ALPHA), PKHD1, PTEN, PTPRD, RARB, RB1, RBM10, RET, RIT1, ROS1, RUNX1T1, SETD2, SMARCA4, TNFAIP3, TP53 (p53)
Squamous Cell Carcinoma​
AKT1, ALK, AMER1, APC, ARID1A, ATM, ADGRB3, BRAF, CDKN2A (P16INK4A), CDKN2B (p15INK4b), CREBBP (CBP), CTNNB1, DDR2, EGFR (ERBB1), EPHA5, ERBB2 (HER-2, NEU), ERBB4, FBXO7, FBXW7, FGFR1, FGFR2, FGFR3, FHIT, GRM8, HRAS, JAK2, KDR (VEGFR3), KEAP1, KIT (CD117), KRAS, LRP1B, MAP2K1, MDM2, MET, MGA, MLH1, KMT2D, MUC16, MYC, NF1, NFE2L2, NOTCH1, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA (p110-alpha), PIK3CG, PIK3R1 (p85-ALPHA), PIK3R2 (p85-BETA), PKHD1, PTEN, PTPRD, RARB, RB1, RBM10, RET, RIT1, ROS1, RUNX1T1, SETD2, SMAD4 (MADH4), SMARCA4, STK11 (LKB1), TNFAIP3, TP53 (p53), TSC1, U2AF1
Acinar Adenocarcinoma​
BRAF, EGFR (ERBB1), KRAS
Adenocarcinoma​
AKT1, ALK, AMER1, APC, ARID1A, ATM, ADGRB3, BAP1, BRAF, CDKN2A (P16INK4A), CDKN2B (p15INK4b), CREBBP (CBP), CTNNB1, DDR2, EGFR (ERBB1), EPHA5, ERBB2 (HER-2, NEU), ERBB4, FBXO7, FBXW7, FGFR1, FGFR2, FGFR3, FHIT, GRM8, HRAS, JAK2, KDR (VEGFR3), KEAP1, KIT (CD117), KRAS, LRP1B, MAP2K1, MDM2, MET, MGA, MLH1, KMT2D, MUC16, MYC, NF1, NFE2L2, NOTCH1, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA (p110-alpha), PIK3CG, PIK3R1 (p85-ALPHA), PIK3R2 (p85-BETA), PKHD1, PTEN, PTPRD, RARB, RASSF1, RB1, RBM10, RET, RIT1, ROS1, RUNX1T1, SETD2, SMAD4 (MADH4), SMARCA4, SOX2, STK11 (LKB1), TNFAIP3, TP53 (p53), TSC1, U2AF1
Blastoma​
CTNNB1, TP53 (p53)
Bronchioalveolar Adenocarcinoma​
CDKN2A (P16INK4A), EGFR (ERBB1), ERBB2 (HER-2, NEU), KRAS, NF1, STK11 (LKB1), TP53 (p53)
Carcinosarcoma​
EGFR (ERBB1)
Giant Cell​
EGFR (ERBB1)
Large Cell​
BRAF, DDR2, CDKN2A (P16INK4A), EGFR (ERBB1), EPHA5, FGFR1, FGFR3, HRAS, KEAP1, KRAS, NRAS, NTRK1, NTRK3, PIK3CA (p110-alpha), STK11 (LKB1), TP53 (p53)
Lymphoepithelioma-Like​
EGFR (ERBB1), TP53 (p53)
Micropapillary Adenocarcinoma​
BRAF, EGFR (ERBB1), KRAS
Mixed Adenosquamous​
EGFR (ERBB1), KRAS, PIK3CA (p110-alpha), STK11 (LKB1), TP53 (p53)
Mixed Small Cell Carcinoma-Adenocarcinoma​
CREBBP (CBP), DDR2, EGFR (ERBB1), TP53 (p53)
Mucoepidermoid Carcinoma​
EGFR (ERBB1)
Oncocytic Adenocarcinoma​
EGFR (ERBB1), KRAS
Pleomorphic Carcinoma​
EGFR (ERBB1), KIT (CD117), KRAS, TP53 (p53)
Sarcomatoid Carcinoma​
EGFR (ERBB1), KRAS
Terminal Respiratory Unit Type Adenocarcinoma​
EGFR (ERBB1)
Undifferentiated Carcinoma​
EGFR (ERBB1), KRAS, MUC16, PKHD1, TP53 (p53)
Other Carcinomas​
ARID1A, CTNNB1, HRAS, NRAS
Other Cancer Subtypes
Hyperplasia​
EGFR (ERBB1), KRAS
Mucinous Proliferation​
KRAS
Neoplasm​
EGFR (ERBB1), KRAS

Resources

Brochures & Guides (6)

Next-generation sequencing using QIAGEN’s QIAseq – a powerful tool for human identification


State-of-the-art technologies to fast-track and streamline NGS workflows
Advanced sample collection, automation and STR solutions for kinship testing
Safety Data Sheets (1)
Kit Handbooks (2)
For ultrasensitive targeted next-generation sequencing (NGS) of DNA for Illumina NGS systems
For ultrasensitive targeted next-generation sequencing (NGS) of DNA for Ion Torrent NGS systems
Certificates of Analysis (1)
Introducing the QIAseq Targeted DNA Human Lung Cancer Panel, a cutting-edge addition to our QIAseq Targeted DNA Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Targeted DNA Human Lung Cancer Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Targeted DNA Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Targeted DNA Human Lung Cancer Panel and elevate your work to new heights.